JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
Saratoga Investment
SAR
$267M
| $483K | ﹤0.01% |
21,698
+9,835
| +83% | +$222K |
2017 Q4
5 quarters
|
|
4052
Carvana
CVNA
$45.9B
| $482K | ﹤0.01% |
41,555
-1,117,245
| -96% | -$9.4M |
2017 Q2
7 quarters
|
|
4053
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$407M
| $479K | ﹤0.01% |
26,058
+23,284
| +839% | +$421K |
2013 Q2
23 quarters
|
|
|
GBL
4054
DELISTED
GAMCO Investors, Inc.
GBL
| $478K | ﹤0.01% |
23,296
-15,386
| -40% | -$304K |
2016 Q4
9 quarters
|
|
4055
Invesco S&P MidCap 400 GARP ETF
GRPM
$501M
| $477K | ﹤0.01% |
7,487
-1,898
| -20% | -$119K |
2018 Q2
3 quarters
|
|
|
VNET
4056
VNET Group
VNET
$1.55B
| $476K | ﹤0.01% |
59,903
+22,535
| +60% | +$202K |
2015 Q2
15 quarters
|
|
|
GEN
4057
DELISTED
Genesis Healthcare, Inc.
GEN
| $475K | ﹤0.01% |
329,969
-63,276
| -16% | -$93.8K |
2016 Q4
9 quarters
|
|
|
EUMV
4058
DELISTED
iShares Edge MSCI Min Vol Europe ETF
EUMV
| $475K | ﹤0.01% |
19,040
+6,102
| +47% | +$147K |
2016 Q2
11 quarters
|
|
|
DENN
4059
DELISTED
Denny's
DENN
| $474K | ﹤0.01% |
25,826
-11,641
| -31% | -$207K |
2017 Q4
5 quarters
|
|
4060
John B. Sanfilippo & Son
JBSS
$796M
| $474K | ﹤0.01% |
6,595
-7,581
| -53% | -$506K |
2013 Q2
23 quarters
|
|
|
RVI
4061
DELISTED
Retail Value Inc. Common Shares
RVI
| $474K | ﹤0.01% |
165,944
-3,072
| -2% | -$8.63K |
2018 Q3
2 quarters
|
|
|
PDLI
4062
DELISTED
PDL BioPharma, Inc.
PDLI
| $474K | ﹤0.01% |
127,518
-81,665
| -39% | -$276K |
2013 Q2
23 quarters
|
|
4063
ATN International
ATNI
$433M
| $473K | ﹤0.01% |
8,373
-13,520
| -62% | -$896K |
2016 Q2
11 quarters
|
|
4064
STAAR Surgical
STAA
$1.13B
| $473K | ﹤0.01% |
13,827
-20,567
| -60% | -$728K |
2017 Q4
5 quarters
|
|
4065
CALL
Coherus Oncology
CHRS
$173M
| $471K | ﹤0.01% |
+34,500
| New | +$460K |
2019 Q1
0 quarters
|
|
4066
Penske Automotive Group
PAG
$13.2B
| $469K | ﹤0.01% |
10,511
+4,814
| +85% | +$213K |
2013 Q2
23 quarters
|
|
4067
CALL
Caesars Entertainment
CZR
$6.04B
| $467K | ﹤0.01% |
+10,000
| New | +$456K |
2019 Q1
0 quarters
|
|
4068
Geospace Technologies
GEOS
$61.4M
| $466K | ﹤0.01% |
35,975
+18,993
| +112% | +$278K |
2015 Q3
14 quarters
|
|
4069
Nathan's Famous
NATH
$416M
| $465K | ﹤0.01% |
6,794
+658
| +11% | +$46.8K |
2016 Q3
10 quarters
|
|
4070
Aaon
AAON
$6.95B
| $463K | ﹤0.01% |
15,038
-775
| -5% | -$20.4K |
2017 Q3
6 quarters
|
|
4071
Navigator Holdings
NVGS
$1.46B
| $463K | ﹤0.01% |
42,089
+410
| +1% | +$4.21K |
2018 Q1
4 quarters
|
|
|
BGG
4072
DELISTED
Briggs & Stratton Corp.
BGG
| $463K | ﹤0.01% |
39,155
-543,120
| -93% | -$7.06M |
2013 Q2
23 quarters
|
|
4073
CALL
Arbutus Biopharma
ABUS
$925M
| $462K | ﹤0.01% |
129,000
+54,000
| +72% | +$207K |
2018 Q3
2 quarters
|
|
|
4074
PUT
Arbutus Biopharma
ABUS
$925M
| $462K | ﹤0.01% |
129,000
+54,000
| +72% | +$207K |
2018 Q3
2 quarters
|
|
4075
Chunghwa Telecom
CHT
$35.8B
| $461K | ﹤0.01% |
12,968
+10,238
| +375% | +$357K |
2018 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.